Mohammad Hirmand

Insider Reports History

Location
C/O Medivation, Inc., 525 Market St., 36 Th Floor, San Francisco, CA
Signature
/s/ Stephen Rodin, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mohammad Hirmand:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Whitehawk Therapeutics, Inc. Director Stock Option (right to buy) 40K Jun 12, 2025 Direct
Turning Point Therapeutics, Inc. EVP and Chief Medical Officer Common Stock 0 $76.00 Aug 17, 2022 Direct
Turning Point Therapeutics, Inc. EVP and Chief Medical Officer Stock Option (right to buy) 0 Aug 17, 2022 Direct

Insider Reports Filed by Mohammad Hirmand

Symbol Company Period Transactions Value $ Form Type Date Filed Role
WHWK Whitehawk Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
AADI Aadi Bioscience, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
AADI Aadi Bioscience, Inc. Mar 27, 2023 1 $0 4 Mar 29, 2023 Director
AADI Aadi Bioscience, Inc. Mar 27, 2023 0 $0 3 Mar 29, 2023 Director
TPTX Turning Point Therapeutics, Inc. Aug 17, 2022 4 -$3.14M 4 Aug 17, 2022 EVP and Chief Medical Officer
TPTX Turning Point Therapeutics, Inc. Feb 9, 2022 4 -$24.3K 4 Feb 11, 2022 EVP & Chief Medical Officer